Inventor · disambiguated record
Paul Edalat
Also filed as: EDALAT PAUL · EDALAT PAUL P
5 granted patents·15 pending applications·12 citations·filing 2008–2022
72Inventor score
Files withVIVERA PHARMACEUTICALS INC16SENTAR PHARMACEUTICALS INC2SCILABS PHARMACEUTICALS1VERIPAK INC1
Top patents by PatentIndex Score
20 records- 0190US11594149B1Speech fluency evaluation and feedbackVIVERA PHARMACEUTICALS INC·Filed 2022·Granted Feb 28, 2023·6 cites·20 claims
- 0282US11450420B2Secure smart dosing system with automated delivery, measurement, and management for pillsVIVERA PHARMACEUTICALS INC·Filed 2021·Granted Sep 20, 2022·1 cites·17 claims
- 0376US11090449B2Smart inhaler device with automated dose delivery, measurement, and managementVIVERA PHARMACEUTICALS INC·Filed 2018·Granted Aug 17, 2021·3 cites·8 claims
- 0473US11083850B2Secure smart dosing system with automated delivery, measurement, and managementVIVERA PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·2 cites·15 claims
- 0572US2022062189A1Sublingual Delivery for Mitigation of Side Effects Associated with Sildenafil CitrateVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0671US2021401757A1Sublingual delivery for mitigation of side effects associated with olanzapine and metforminVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0771US2021401758A1Sublingual delivery for mitigation of side effects associated with trazodoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0870US2023104820A1Self-Contained, Portable, Sanitization Device and Telemedicine StationVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0965US11406728B2Self-contained, portable, sanitization device and telemedicine stationVIVERA PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·0 cites·7 claims
- 1059US2019175513A1All natural, non-toxic sublingual drug delivery systemsSENTAR PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1157US2016331693A1All natural, non-toxic sublingual drug delievery systemsSCILABS PHARMACEUTICALS·Filed 2014·Application pending·0 cites
- 1255US2017266118A1All natural, non-toxic sublingual drug delivery systemsSENTAR PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1354US2023114360A1Sublingual Delivery for Mitigation of Side Effects Associated with ZicronapineVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1452US2022023223A1Sublingual delivery for mitigation of side effects associated with blonanserinVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1550US2022168226A1Sublingual delivery for mitigation of side effects associated with metforminVIVERA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1650US2022117900A1Sublingual delivery for mitigation of side effects associated with vortioxetineVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1750US2022096387A1Sublingual delivery for mitigation of side effects associated with lurasidoneVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1850US2022117901A1Sublingual delivery for mitigation of side effects associated with brexpiprazoleVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1948US2021311056A1Self-administered infection testing and result determinationVIVERA PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2043US2009068300A1Pre- and post-workout formulations processes and supplement products therebyVERIPAK INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Edalat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →